To include your compound in the COVID-19 Resource Center, submit it here.

Apixaban: Preliminary Phase III data

Preliminary data from the double-blind, international Phase III AVERROES trial in 5,600 patients showed that apixaban was superior to aspirin on the annual rate of the composite primary endpoint of stroke or

Read the full 323 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE